WDR51A activators constitute a specialized class of compounds designed to target and enhance the activity of the WDR51A protein. WDR51A, or WD Repeat Domain 51A, is a member of the WD repeat protein family, characterized by its multiple WD repeats, which are protein-protein interaction domains. WD repeat proteins are involved in a wide range of cellular processes, including signal transduction, protein trafficking, and chromatin remodeling. WDR51A, specifically, is associated with various cellular functions, including nucleolar organization and ribosome biogenesis. Activators of WDR51A are designed to upregulate its biological activity or stability, potentially influencing its role in nucleolar function and ribosome assembly. These activators may encompass a range of chemical structures, from small organic molecules to larger biomolecules, each selectively interacting with WDR51A to modulate its function within cells.
Research into WDR51A activators typically involves a multidisciplinary approach, combining techniques from cell biology, biochemistry, and molecular biology to elucidate their effects on WDR51A function and their impact on nucleolar and ribosomal processes. Scientists investigate the interaction between WDR51A and its activators by examining changes in nucleolar morphology, ribosome assembly, and cellular growth. Commonly used techniques include immunofluorescence microscopy to visualize nucleolar structures, sucrose gradient centrifugation to analyze ribosome subunit profiles, and RNA sequencing to assess changes in ribosomal RNA processing. Additionally, genetic and functional assays in cell lines and model organisms may be employed to study the consequences of WDR51A activation on cellular physiology. Through these investigations, researchers aim to understand the specific cellular pathways regulated by WDR51A, how its activity is controlled, and how modulation by specific activators can impact nucleolar organization and ribosome biogenesis, contributing to a deeper understanding of fundamental cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid can modulate gene expression via various signaling pathways, potentially influencing WDR51A expression. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
As a PPARγ agonist, pioglitazone can regulate gene transcription, which may hypothetically affect WDR51A expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid that can regulate gene expression through glucocorticoid receptor signaling, possibly impacting WDR51A. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
17-β Estradiol exerts gene regulatory effects via estrogen receptors, which could influence the expression of WDR51A. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, which can lead to changes in transcriptional profiles, potentially including WDR51A. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter downstream signaling and gene expression, possibly affecting WDR51A expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, potentially altering gene expression profiles, including that of WDR51A. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that can change gene expression through the MAPK/ERK pathway, potentially influencing WDR51A. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
BIX-01294 is a G9a histone methyltransferase inhibitor that may change chromatin dynamics and gene expression, possibly including WDR51A. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is a histone deacetylase inhibitor that can lead to a more relaxed chromatin state and upregulation of genes, potentially WDR51A. | ||||||